Results 211 to 220 of about 78,086 (312)
Metabolomic profiling and vitamin D pathway investigation in diabetic foot ulcer patients. [PDF]
Reveendran R +5 more
europepmc +1 more source
Frameworks for Action: A Scoping Review of Organisational Patient Engagement Models in Healthcare
ABSTRACT Objective Patient engagement (PE) is recognised as a key pillar of healthcare planning and delivery. However, there is a limited understanding of recent evidence‐based organisational frameworks supporting PE; this gap can impact the uptake, implementation, and spread of PE efforts across healthcare organisations. Our study aims to identify and
Titus A. Chan +2 more
wiley +1 more source
Multidrug resistance and inappropriate empiric therapy as predictors of hospital stay in diabetic foot infections. [PDF]
Zuriegat L +3 more
europepmc +1 more source
An early first pregnancy is protective against postmenopausal breast cancer. However, pregnancy is also a key contributor to weight gain, and adult weight gain increases postmenopausal breast cancer risk. This prospective cohort study quantified the combined effect of adult weight gain and age at first pregnancy on postmenopausal breast cancer risk ...
Lee Malcomson +7 more
wiley +1 more source
Improving Diabetic Foot Care With Infrared Thermography and Artificial Intelligence: A Review. [PDF]
Teixeira P, Filipe V, Teixeira A.
europepmc +1 more source
Gout in pregnancy: Obstetric and neonatal outcomes
Abstract Objective The pregnancy, delivery, and neonatal outcomes of pregnancies complicated by gout have yet to be evaluated in a population‐based study. We sought to evaluate the obstetric and neonatal outcomes in pregnant patients with gout using a national population database.
Sam Amar +3 more
wiley +1 more source
Risk Factors for Diabetic Foot Ulcers and the Role of Thermal Imaging in Early Detection. [PDF]
Damoune I +5 more
europepmc +1 more source
Abstract Objective To develop and internally validate a mechanistic, three‐domain framework for early classification and prediction of pre‐eclampsia (PE) using first‐trimester angiogenic, uteroplacental, and maternal vascular biomarkers. Methods In a prospective cohort of 1925 singleton pregnancies screened at 11 to 13.6 weeks, placental growth factor (
Johnatan Torres‐Torres +8 more
wiley +1 more source

